medicine-technology-1/popular-breast-cancer-drug-used-with-certain-antidepressants-puts-new-jersey-women-at-risk-4797-4/;+health+history;+medical+history.html

Breaking Biology Technology:New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2 New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3 Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2 Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3 Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2 Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2 Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3

[0] New silicon-germanium nanowires could lead to smaller, more powerful electronic devices [0] Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum [0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease [0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease

Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5 Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2 NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 1 NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 2 NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 3 NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 4 Formatech Inc to Donate Services to Formulate and Fill GeoVax Labs Inc HIV AIDS Vaccine Under Its Fillanthropy 28TM 29 Program 14492 1 Formatech Inc to Donate Services to Formulate and Fill GeoVax Labs Inc HIV AIDS Vaccine Under Its Fillanthropy 28TM 29 Program 14492 2 Formatech Inc to Donate Services to Formulate and Fill GeoVax Labs Inc HIV AIDS Vaccine Under Its Fillanthropy 28TM 29 Program 14492 3 Formatech Inc to Donate Services to Formulate and Fill GeoVax Labs Inc HIV AIDS Vaccine Under Its Fillanthropy 28TM 29 Program 14492 4 Skin cells may provide early warning for cancer risk elsewhere in body 59563 1 Skin cells may provide early warning for cancer risk elsewhere in body 59563 2 Skin cells may provide early warning for cancer risk elsewhere in body 59563 3

[0] Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy [0] Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy [0] Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program